| Dr Michael Bruce Sherman, MD | |
|
15 S Main St, Marlboro, NJ 07746-1595 | |
| (732) 303-8787 | |
| (732) 303-7870 |
| Full Name | Dr Michael Bruce Sherman |
|---|---|
| Gender | Male |
| Speciality | Allergy/immunology |
| Experience | 34 Years |
| Location | 15 S Main St, Marlboro, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124019930 | NPI | - | NPPES |
| 7008503 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | MA64347 (New Jersey) | Primary |
| Entity Name | Allergy & Asthma Center Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104036789 PECOS PAC ID: 9830109065 Enrollment ID: O20060502000530 |
News Archive
The sexual and feminist revolutions were supposed to free women to enjoy casual sex just as men always had. Yet according to Professor Anne Campbell from Durham University in the UK, the negative feelings reported by women after one-night stands suggest that they are not well adapted to fleeting sexual encounters. Her findings are published online in the June issue of Springer's journal, Human Nature.
Novel measures of brain activity associated with Parkinson's disease can be detected with scalp electrodes, according to a new analysis published in eNeuro. Such a marker of PD — detected using a noninvasive, affordable approach — could improve management of the disease by doctors and patients, particularly in rural areas.
Kamada Ltd., a plasma-derived protein therapeutics company focused on orphan indications, announces preliminary top-line results from the Phase II/III pivotal clinical trial in Europe and Canada of the Company's proprietary inhaled Alpha-1 Antitrypsin (AAT) therapy for the treatment of Alpha-1 Antitrypsin Deficiency (AATD or inherited emphysema).
Researchers from the Flanders Interuniversity Institute for Biotechnology (VIB) at Ghent University are joining the fight against chronic intestinal disease with a genetically modified bacterium (Lactococcus lactis).
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Bruce Sherman, MD 15 S Main St, Marlboro, NJ 07746-1595 Ph: (732) 303-8787 | Dr Michael Bruce Sherman, MD 15 S Main St, Marlboro, NJ 07746-1595 Ph: (732) 303-8787 |
News Archive
The sexual and feminist revolutions were supposed to free women to enjoy casual sex just as men always had. Yet according to Professor Anne Campbell from Durham University in the UK, the negative feelings reported by women after one-night stands suggest that they are not well adapted to fleeting sexual encounters. Her findings are published online in the June issue of Springer's journal, Human Nature.
Novel measures of brain activity associated with Parkinson's disease can be detected with scalp electrodes, according to a new analysis published in eNeuro. Such a marker of PD — detected using a noninvasive, affordable approach — could improve management of the disease by doctors and patients, particularly in rural areas.
Kamada Ltd., a plasma-derived protein therapeutics company focused on orphan indications, announces preliminary top-line results from the Phase II/III pivotal clinical trial in Europe and Canada of the Company's proprietary inhaled Alpha-1 Antitrypsin (AAT) therapy for the treatment of Alpha-1 Antitrypsin Deficiency (AATD or inherited emphysema).
Researchers from the Flanders Interuniversity Institute for Biotechnology (VIB) at Ghent University are joining the fight against chronic intestinal disease with a genetically modified bacterium (Lactococcus lactis).
› Verified 4 days ago